Skip to main content
Sofwave Medical Ltd. logo

Sofwave Medical Ltd. — Investor Relations & Filings

Ticker · SOFW ISIN · IL0011754392 TA Manufacturing
Open in API
Filings indexed 38 across all filing types
Latest filing 2026-03-17 Investor Presentation
Country IL Israel
Listing TA SOFW

About Sofwave Medical Ltd.

https://sofwave.com

Sofwave Medical Ltd. is an aesthetic medical device company that develops and markets non-invasive energy-based solutions for skin rejuvenation and body contouring. The company's core technology, SUPERB™ (Synchronous Ultrasound Parallel Beam), utilizes high-frequency ultrasound to precisely heat mid-dermal tissue, stimulating the natural production of collagen, elastin, and hyaluronic acid. Its treatments are FDA-cleared for lifting the eyebrows, neck, and submental area, as well as improving fine lines, wrinkles, and the appearance of cellulite. The company also offers Pure Impact™, a bio-electrical muscle stimulation (EMS) technology for strengthening, toning, and firming muscles. Sofwave's solutions are designed to be safe for all skin types, offering clinically proven, natural-looking results with minimal downtime.

Recent filings

Filing Released Lang Actions
INVESTORS PRESENTATION-Q4 2025
Investor Presentation Classification · 100% confidence The document is a slide deck titled 'Investor Meeting March 2026' containing financial highlights, market analysis, and product information for Sofwave Medical Ltd. It includes detailed financial tables for Q4 2025 and FY 2025, growth metrics, and strategic outlooks. This is a classic investor presentation used to communicate performance and strategy to shareholders and analysts.
2026-03-17 English
INVESTORS PRESENTATION-Q4 2025
Call Transcript Classification · 95% confidence The document is a short regulatory filing (Magna system) from Sofwave Medical Ltd. that serves as a cover letter or announcement for an attached investor presentation ('מצגת למשקיעים'). It explicitly states that the presentation is attached and provides context for its release. According to the 'Menu vs Meal' rule, since this is a short announcement document (under 5,000 characters) notifying the public of an attached presentation, it is classified as a Report Publication Announcement (RPA).
2026-03-17 Russian
Presentations - Q3 2025
Investor Presentation Classification · 100% confidence The document is a slide deck titled 'Investor meeting August 2025' for Sofwave Medical Ltd. It contains financial highlights for Q3 2025, market trends, product technology comparisons, and FDA clearance information. It is clearly designed for an investor audience to showcase company performance and strategy, fitting the definition of an Investor Presentation.
2025-11-04 English
Presentations - Q3 2025
Report Publication Announcement Classification · 100% confidence The document is a regulatory filing from the Israel Securities Authority (ISA) MAGNA system. It is a 'Immediate Report' (דוח מיידי) that explicitly states the nature of the event is an 'Investor Presentation' (מצגת למשקיעים). The text confirms that a presentation file is attached for investors and provides context regarding the company's financial outlook. Since the document is a formal announcement of an investor presentation being filed with the regulator, it falls under the category of Investor Presentation.
2025-11-04 Russian
Presentation-Q2 2025
Investor Presentation Classification · 100% confidence The document is a detailed slide deck titled 'Q2 2025 Summary' for Sofwave Medical Ltd. It contains financial highlights, market trends, product information, and strategic pillars. It is clearly intended for an investor audience, as evidenced by the 'Investor meeting August 2025' header, the presence of forward-looking statements, and detailed financial performance metrics (P&L, revenue growth, etc.). It is not a formal 10-K or quarterly report, but rather a presentation used to communicate these results to investors.
2025-08-05 English
Presentation-Q2 2025
Earnings Release Classification · 99% confidence The document is a formal regulatory filing (Magna system) from Sofwave Medical Ltd. It explicitly states the nature of the event as 'Investor Presentation' (מצגת למשקיעים) and includes a link to an attached PDF file. According to the 'Menu vs Meal' rule, since this is a short regulatory cover form announcing the availability of an investor presentation, it is classified as an Investor Presentation (IP). H1 2025
2025-08-05 Russian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.